UOC
TMCI icon

UBS O'Connor’s Treace Medical Concepts TMCI Stock Holding History

UBS O'Connor’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100,317
Closed -$590K – 441
2025
Q2 		$590K Sell
100,317
-47,378
-32% -$309K 0.02% 265
2025
Q1 		$1.24M Sell
147,695
-126,505
-46% -$1.14M 0.03% 165
2024
Q4 		$2.04M Buy
274,200
+56,445
+26% +$378K 0.05% 154
2024
Q3 		$1.26M Buy
217,755
+4,779
+2% +$30.7K 0.03% 249
2024
Q2 		$1.42M Buy
212,976
+77,063
+57% +$623K 0.04% 246
2024
Q1 		$1.77M Sell
135,913
-19,000
-12% -$253K 0.05% 194
2023
Q4 		$1.98M Sell
154,913
-18,091
-10% -$183K 0.06% 173
2023
Q3 		$2.27M Buy
173,004
+60,551
+54% +$1.11M 0.04% 224
2023
Q2 		$2.88M Sell
112,453
-33,106
-23% -$854K 0.06% 200
2023
Q1 		$3.67M Buy
145,559
+2,250
+2% +$52.8K 0.09% 184
2022
Q4 		$3.29M Buy
143,309
+10,672
+8% +$246K 0.06% 297
2022
Q3 		$2.93M Sell
132,637
-6,000
-4% -$116K 0.03% 440
2022
Q2 		$1.99M Buy
138,637
+79,349
+134% +$1.34M 0.02% 657
2022
Q1 		$1.12M Buy
+59,288
New +$1.15M 0.01% 678

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS O'Connor's TMCI Position: Q3 2025 in Review

UBS O'Connor sold out of Treace Medical Concepts (TMCI) in Q3 2025, closing a stake of 100,317 shares — an estimated $590K sold.

UBS O'Connor first reported a position in TMCI in Q1 2022 and held it in 14 quarters. The position peaked at $3.67M in Q1 2023. 119 funds tracked by Wall St. Rank hold TMCI as of Q3 2025.

  • UBS O'Connor reported no remaining Treace Medical Concepts position as of Q3 2025 after selling out during the quarter.
  • UBS O'Connor sold 100,317 Treace Medical Concepts shares in Q3 2025, an estimated $590K.
  • UBS O'Connor first reported a position in Treace Medical Concepts in Q1 2022 and held it in 14 quarters.
  • UBS O'Connor's Treace Medical Concepts position peaked at $3.67M in Q1 2023.
  • 119 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.